Charles G. Drake
- Immunology top 0.02%
- Immunotherapy and Immune Responses 138
- Immune Cell Function and Interaction 54
- Oncology top 0.02%
- Cancer Immunotherapy and Biomarkers 230
- CAR-T cell therapy research 50
- Neurology top 0.02%
- Intracranial Aneurysms: Treatment and Complications 77
- Vascular Malformations Diagnosis and Treatment 40
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research 109
- Renal cell carcinoma treatment 39
- Cancer Research top 0.2%
- Co-authors
- Drew M. PardollSuzanne L. TopalianSydney J. PeerlessAllan J. FoxEvan J. LipsonDario A.A. VignaliAngelo M. De MarzoFernando Viñuela
- Cited by
- ImmunologyOncologyNeurology
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Charles G. Drake
478 papers receiving 39.0k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Immunology 16.0k
- Oncology 18.6k
- Neurology 9.2k
- Pulmonary and Respiratory Medicine 10.0k
- Cancer Research 3.2k
Countries citing papers authored by Charles G. Drake
This map shows the geographic impact of Charles G. Drake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles G. Drake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles G. Drake more than expected).
Fields of papers citing papers by Charles G. Drake
This network shows the impact of papers produced by Charles G. Drake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles G. Drake. The network helps show where Charles G. Drake may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles G. Drake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 39 | |
| 2 | 2020 | 7 | |
| 3 | 2020 | 35 | |
| 4 | 2018 | 26 | |
| 5 | 2018 | 67 | |
| 6 | 2017 | 56 | |
| 7 | 2017 | 28 | |
| 8 | 2017 | 166 | |
| 9 | 2016 | 133 | |
| 10 | 2016 | 41 | |
| 11 | 2016 | 60 | |
| 12 | 2015 | 101 | |
| 13 | 2015 | 54 | |
| 14 | 2015 | 34 | |
| 15 | Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigenbreakdown → | 2014 | 510 |
| 16 | 2014 | 18 | |
| 17 | Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinomabreakdown → | 2013 | 602 |
| 18 | 2011 | 434 | |
| 19 | 2009 | 122 | |
| 20 | 2009 | 245 |
About Charles G. Drake
Charles G. Drake is a scholar working on Oncology, Immunology and Neurology, having authored 490 papers that have together received 40.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (230 papers), Immunotherapy and Immune Responses (138 papers), Prostate Cancer Treatment and Research (109 papers), Intracranial Aneurysms: Treatment and Complications (77 papers), Immune Cell Function and Interaction (54 papers), CAR-T cell therapy research (50 papers), Vascular Malformations Diagnosis and Treatment (40 papers) and Renal cell carcinoma treatment (39 papers). The work is most often cited by research in Immunology (16.0k citations), Oncology (18.6k citations) and Neurology (9.2k citations). Charles G. Drake has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Drew M. Pardoll, Suzanne L. Topalian, Sydney J. Peerless, Allan J. Fox, Evan J. Lipson, Dario A.A. Vignali, Angelo M. De Marzo, Fernando Viñuela, Robert A. Anders and Julie R. Brahmer. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.